Abstract
Highlights from the New Drug Session at the Biennial International Congress on Schizophrenia Research, April 2�??6, 2011
Author(s): Hakon HeimerThe 2011 International Congress on Schizophrenia Research, held in Colorado Springs, Colorado, attracted nearly 1,200 attendees to the Broadmoor Hotel from 2–6 April 2011, not to mention the satellite meetings on cognition and the schizophrenia prodrome. With the gracious assistance of Congress directors Carol Tamminga and Chuck Schulz, as well as meeting staff Dorothy Denton and Cristan Tamminga, we bring you the following report on the Congress’ “New Drug Session: Advances in Medication Development and Assessment.”